![](/img/cover-not-exists.png)
1174PKRAS mutations (KRAS-mut) and antiPD1/PDL1 therapy in a cohort of non-small cell lung cancer (NSCLC) patients (p): Experience from a single institution
Erasun Lecuona, C., Moran Bueno, M.T., Vila, L., Teruel, I., Angelats, L., Ferrando, A., Plaja, A., Torres, P., Lopez, E., Muriel, R., Muñoz-Marmol, A.M., Mate, J.L., Velarde, J.M., Carcereny Costa, EVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx376.039
Date:
September, 2017
File:
PDF, 46 KB
english, 2017